TP53 and neoplasm: To validate the results, we selected 3 cell lines of different tumor types, that presented different sensitivities to TTFields and various mutational burden: lung A549 cells—low TTFields sensitivity, intermediate mutational burden (wild type TP53); gastric AGS cells—high TTFields sensitivity, high mutational burden (wild type TP53); and pancreatic AsPC1 cells—low TTFields sensitivity, low mutational burden (mutated TP53).